Report Categories
View AllRecent Articles
View All
LION Lionsgate posts Q1 2026 earnings beat and 7 percent revenue growth shares dip 252 percent
Super SGHC Stock Resistance Test Overview 412 20260420
Gabelli GAB Stock Sum of Parts Risk Aversion 20260420
Morgan Stanley MS Analysis of PreIPO SpaceX Access Vehicles Amid Rising Private Market Liquidity Risks
ASPCU A SPAC III updates investors on its active target acquisition search progress in quarterly earnings release
The biggest catalyst for ARS Pharmaceuticals SPRY nobody is watching Momentum Fading 20260508
State Street Materials Select Sector SPDR ETF XLB HighPotential Cyclical Play Amid Broad SP 500 Earnings Resilience
What would it take for DR Horton DHI to double from here Breakout Watch 20260505
FUNC First delivers 123 percent Q4 2025 EPS surprise shares rise slightly after earnings release
Penske PAG Stock Analysis 129 Loss Key Levels 20260518
Regional Management RM Q1 2026 Earnings EPS 118 Beats Estimates
New Found NFGC Drops 354 Key Support at 181 20260519
Nuveen NCDL Down 128 How Low Could It Go 20260518
UnitedGuardian UG Earnings Outlook Key Metrics for Q2 2025
Conoco COP Down 197 How Low Could It Go 20260520
Scienture Holdings SCNX Q1 2026 Earnings Surprise EPS 008 Up Significant
Joscelyn Robersons Transfer to Georgia Could Reshape College Gymnastics Landscape
PubMatic Q1 2026 Earnings EPS Beats Estimates Shares Inch Higher
Prairie Operating Co PROP Q1 2026 Earnings Wide EPS Miss Amid No Revenue
KLAR Q1 2026 Earnings Net Loss Narrows Sharply Beating Estimates by Wide Margin
KOS Q1 2026 Earnings EPS Miss Weighs on Shares as Operating Environment Challenges Persist
OUT Q1 2026 Earnings Strong EPS Surprise Highlights Operational Resilience
PLAYSTUDIOS Inc MYPS Surges 989 as Price Approaches Key Resistance at 051
CRISPR Therapeutics CRSP Edges Higher as GeneEditing Sector Regains Traction
Extreme Networks Dips 130 as Stock Tests Key Support Levels
GPAct III Acquisition Corp GPAT Holds Steady at 1080 as SPAC Awaiting Next Catalyst
External Links
Why Lennar Corporation LEN deserves more attention from serious investors At Lows 20260511
Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations
Warrior Met Coal HCC Q1 2026 Earnings EPS Misses Estimates Amid Margin Headwinds
TIGR Q4 2025 Earnings EPS Beats Estimates as Stock Plunges 25
CTNT Q1 2026 Earnings EPS Beats Estimates Despite Negative Earnings Stock Drops
FTAIN Q1 2026 Earnings Miss on Bottom Line as Preferred Shares Hold Steady
VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline
Hub Group Q3 2025 Earnings Slight EPS Miss Amid Mixed Freight Conditions
MasTec MTZ Q1 2026 Earnings Strong EPS Beat Drives Optimism Despite Stock Dip